Aquaporin 1, Aquaporin 8, and Aquaporin 9 Expressions in Malignant Melanoma: A Possible Correlation with Prognosis and Clinical Outcome.
Lara CamilloElia EspostoLaura Cristina GironiChiara AiroldiShahd Abdullah AlhamedRenzo Luciano BoldoriniElisa ZavattaroPaola SavoiaPublished in: Journal of clinical medicine (2023)
Aquaporins (AQPs) are small transmembrane proteins able to facilitate the passive transport of water and small molecules throughout cells. Several studies have demonstrated that modulation of AQPs' expression contributes to cancer development and progression. However, to date, very little is known about their involvement in malignant melanoma (MM) progression. In this retrospective observational study, we evaluated the correlation between AQP1, -8, and -9 expression and the clinical outcomes of 58 patients diagnosed with MM from 2014 to 2016, of which 14 were diagnosed as nodular melanoma (NM) and 44 as superficial spreading melanoma (SSM). In general, we found that AQPs were more highly expressed in SSM than NM, suggesting a potential correlation with prognosis. While analyzing the expression of each AQP, we discovered that AQP1 was associated with a specific body site and low mitotic index, AQP8 with a negative sentinel lymph node, and AQP9 with the Breslow thickness and lack of ulcerations. Together with the survival analysis performed in this study, our results suggest that the expression of AQP1, -8, and -9 could be correlated with a better prognosis for malignant melanoma.
Keyphrases
- poor prognosis
- sentinel lymph node
- end stage renal disease
- long non coding rna
- chronic kidney disease
- early stage
- newly diagnosed
- lymph node
- induced apoptosis
- squamous cell carcinoma
- peritoneal dialysis
- prognostic factors
- signaling pathway
- risk assessment
- oxidative stress
- cross sectional
- papillary thyroid
- cell death
- young adults
- cell cycle arrest
- patient reported outcomes
- endoplasmic reticulum stress
- pi k akt